Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

VALIRX PLC AGM Information 2013

Apr 22, 2013

7998_dva_2013-04-22_e382e3a0-e44a-4a46-a39a-dd86e6810145.html

AGM Information

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9006C

ValiRx PLC

22 April 2013

ValiRx plc

("ValiRx" or the "Company")

Result of AGM

ValiRx (AIM: VAL), a life science company with a focus on cancer diagnostics and therapeutics for personalised medicine, announces that at the Annual General Meeting of the Company held earlier today, all resolutions were duly passed.

Enquiries:

ValiRx plc

Dr Satu Vainikka
Tel: +44 (0)20 3008 4416

www.ValiRx.com
Cairn Financial Advisers LLP (Nominated Adviser)

Liam Murray / Avi Robinson
Tel: +44 (0)20 7148 7900
Hybridan LLP (Broker)

Claire Noyce/Deepak Reddy
Tel: + 44 (0)20 7947 4350
Peckwater PT

Tarquin Edwards
Tel: +44 (0)7879 458 364

[email protected]

This information is provided by RNS

The company news service from the London Stock Exchange

END

RAGSESFSEFDSEIL